Patents Assigned to Triomed AB
-
Patent number: 11590269Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a tube set including a connector (21) for connection to a patient line (3) for access to the peritoneal cavity of the patient. A flow pump (41-43) is arranged for addition and removal outflow and inflow (recirculation) of fluid from/to the peritoneal cavity. An osmotic agent peristaltic pump (16) is arranged for replenishment of glucose solution to the fluid added to the peritoneal cavity for promoting ultrafiltration. The glucose is replenished intermittently for keeping a concentration of glucose substantially constant in the peritoneal cavity. The flow pump comprises a pressure chamber (43) with rigid walls and a flexible pump bag (41) arranged therein. An air pump (45) pressurizes the chamber for outflow of fluid from the peritoneal cavity by a sub pressure and inflow of fluid to the peritoneal cavity by an overpressure, which pressures are maintained within safe limits.Type: GrantFiled: February 27, 2020Date of Patent: February 28, 2023Assignee: TRIOMED ABInventors: Mikael Axelsson, Stefan Landholm, Eva Persson, Hans Bengtsson
-
Patent number: 11583621Abstract: A cartridge to be used for adsorption dialysis. A container having flexible walls are arranged to provide an inner space enclosing adsorption powder, comprising activated carbon, a phosphate adsorbent and a potassium ion adsorbent and other adsorbents. A sufficient amount of activated carbon is provided for adsorption of urea by the activated carbon. The cartridge forms a vacuum-packed transportation cartridge by generating a sub-pressure in the inner space, whereby the powder particles are immobilized and the cartridge becomes stiff. Before use, the cartridge is primed by introducing a liquid into the inner space, which introduction takes place at a low pressure. During use, dialysis solution is circulated through the cartridge, which is still exposed to a sub-pressure, whereby the flexible walls are sucked against the powder material.Type: GrantFiled: May 27, 2016Date of Patent: February 21, 2023Assignee: TRIOMED ABInventors: Anders Wallenås, Nina Meinander, Carin Malmborg, Stefan Landholm, Hans Bengtsson
-
Patent number: 10946130Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure. The apparatus comprises a dilution syringe for removal of a portion of peritoneal fluid from the peritoneal cavity. A glucose bag comprises glucose concentrate at a concentration of 30%. A small amount of glucose concentrate is mixed with the dilution fluid in the dilution syringe in order to dilute the glucose concentrate to below 3% concentration. Then, the mixture is filled into the peritoneal cavity from the dilution syringe in order to replenish the glucose in the peritoneal cavity for maintaining a substantially constant glucose concentration in the peritoneal cavity. In addition, peritoneal fluid is intermittently removed from the peritoneal cavity for counteracting increased intraperitoneal fluid volume and increased intraperitoneal pressure due to ultrafiltration. A UF bag is arranged for receiving such surplus peritoneal fluid. A glucose syringe may be arranged for metering the glucose concentrate.Type: GrantFiled: August 26, 2016Date of Patent: March 16, 2021Assignee: TRIOMED ABInventor: Hans Bengtsson
-
Publication number: 20200338251Abstract: Method and apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a cassette having four inlets/outlets. A patient tube is connected to a patient connector, intended to be connected to a patient line for access to a peritoneal cavity of the patient. The patient tube comprises a flow pump for addition and removal of a peritoneal fluid between the cassette and the peritoneal cavity. The fluid is introduced into an intermittent bag controlled by an intermittent valve and then returned the same way back to the peritoneal cavity. Glucose is metered into the fluid entering the peritoneal cavity by means of a glucose pump. Glucose is replenished continuously or intermittently for keeping a concentration of the osmotic agent substantially constant in the peritoneal cavity. After treatment, the peritoneal fluid is drained to a drain bag, wherein the drain tube comprises a drain valve and an albumin filter.Type: ApplicationFiled: July 9, 2020Publication date: October 29, 2020Applicant: TRIOMED ABInventors: Anders WALLENÅS, Lars WRAMNER, Stefan LANDHOLM
-
Patent number: 10709831Abstract: Method and apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a cassette having four inlets/outlets. A patient tube is connected to a patient connector, intended to be connected to a patient line for access to a peritoneal cavity of the patient. The patient tube comprises a flow pump for addition and removal of a peritoneal fluid between the cassette and the peritoneal cavity. The fluid is introduced into an intermittent bag controlled by an intermittent valve and then returned the same way back to the peritoneal cavity. Glucose is metered into the fluid entering the peritoneal cavity by means of a glucose pump. Glucose is replenished continuously or intermittently for keeping a concentration of the osmotic agent substantially constant in the peritoneal cavity. After treatment, the peritoneal fluid is drained to a drain bag, wherein the drain tube comprises a drain valve and an albumin filter.Type: GrantFiled: February 27, 2015Date of Patent: July 14, 2020Assignee: TRIOMED ABInventors: Anders Wallenås, Lars Wramner, Stefan Landholm
-
Publication number: 20200188570Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a tube set including a connector (21) for connection to a patient line (3) for access to the peritoneal cavity of the patient. A flow pump (41-43) is arranged for addition and removal outflow and inflow (recirculation) of fluid from/to the peritoneal cavity. An osmotic agent peristaltic pump (16) is arranged for replenishment of glucose solution to the fluid added to the peritoneal cavity for promoting ultrafiltration. The glucose is replenished intermittently for keeping a concentration of glucose substantially constant in the peritoneal cavity. The flow pump comprises a pressure chamber (43) with rigid walls and a flexible pump bag (41) arranged therein. An air pump (45) pressurizes the chamber for outflow of fluid from the peritoneal cavity by a sub pressure and inflow of fluid to the peritoneal cavity by an overpressure, which pressures are maintained within safe limits.Type: ApplicationFiled: February 27, 2020Publication date: June 18, 2020Applicant: TRIOMED ABInventors: Mikael AXELSSON, Stefan LANDHOLM, Eva PERSSON, Hans BENGTSSON
-
Publication number: 20200164129Abstract: A dialysis device comprising a dialysis circuit for providing dialysis fluid and returning purified fluid to the dialysis circuit. The device comprises an evaporator/condenser device, provided with an evaporator bag and a condenser bag. The evaporator bag receives dialysis fluid from the dialysis bag and produces steam, whereby a concentrated dialysis fluid is left and drained to a drain bag. The condenser bag receives the steam produced in the evaporation bag and condenses the steam for producing pure water for being returned to said dialysis circuit. The evaporation and condensation takes place at a subatmospheric pressure, such as between 30 and 70 mmHg at a temperature of about 30 to 44° C. Heat energy is provided to the evaporation bag and the condenser bag is cooled. The cooled energy may be absorbed by a heat pump for delivery of heat to the evaporator bag.Type: ApplicationFiled: July 13, 2018Publication date: May 28, 2020Applicant: TRIOMED ABInventor: Anders WALLENÅS
-
Patent number: 10576195Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a tube set including a connector for connection to a patient line for access to the peritoneal cavity of the patient. A flow pump is arranged for addition and removal outflow and inflow (recirculation) of fluid from/to the peritoneal cavity. An osmotic agent peristaltic pump is arranged for replenishment of glucose solution to the fluid added to the peritoneal cavity for promoting ultrafiltration. The glucose is replenished intermittently for keeping a concentration of glucose substantially constant in the peritoneal cavity. The flow pump comprises a pressure chamber with rigid walls and a flexible pump bag arranged therein. An air pump pressurizes the chamber for outflow of fluid from the peritoneal cavity by a sub pressure and inflow of fluid to the peritoneal cavity by an overpressure, which pressures are maintained within safe limits.Type: GrantFiled: November 20, 2015Date of Patent: March 3, 2020Assignee: TRIOMED ABInventors: Mikael Axelsson, Stefan Landholm, Eva Persson, Hans Bengtsson
-
Publication number: 20180169318Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure. The apparatus comprises a dilution syringe for removal of a portion of peritoneal fluid from the peritoneal cavity. A glucose bag comprises glucose concentrate at a concentration of 30 %. A small amount of glucose concentrate is mixed with the dilution fluid in the dilution syringe in order to dilute the glucose concentrate to below 3 % concentration. Then, the mixture is filled into the peritoneal cavity from the dilution syringe in order to replenish the glucose in the peritoneal cavity for maintaining a substantially constant glucose concentration in the peritoneal cavity. In addition, peritoneal fluid is intermittently removed from the peritoneal cavity for counteracting increased intraperitoneal fluid volume and increased intraperitoneal pressure due to ultrafiltration. A UF bag is arranged for receiving such surplus peritoneal fluid. A glucose syringe may be arranged for metering the glucose concentrate.Type: ApplicationFiled: August 26, 2016Publication date: June 21, 2018Applicant: TRIOMED ABInventor: Hans BENGTSSON
-
Publication number: 20180140765Abstract: A cartridge to be used for adsorption dialysis. A container having flexible walls are arranged to provide an inner space enclosing adsorption powder, comprising activated carbon, a phosphate adsorbent and a potassium ion adsorbent and other adsorbents. A sufficient amount of activated carbon is provided for adsorption of urea by the activated carbon. The cartridge forms a vacuum-packed transportation cartridge by generating a sub-pressure in the inner space, whereby the powder particles are immobilized and the cartridge becomes stiff. Before use, the cartridge is primed by introducing a liquid into the inner space, which introduction takes place at a low pressure. During use, dialysis solution is circulated through the cartridge, which is still exposed to a sub-pressure, whereby the flexible walls are sucked against the powder material.Type: ApplicationFiled: May 27, 2016Publication date: May 24, 2018Applicant: TRIOMED ABInventors: Anders WALLENÅS, Nina MEINANDER, Carin MALMBORG, Stefan LANDHOLM, Hans BENGTSSON
-
Publication number: 20170281848Abstract: An apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a tube set including a connector for connection to a patient line for access to the peritoneal cavity of the patient. A flow pump is arranged for addition and removal outflow and inflow (recirculation) of fluid from/to the peritoneal cavity. An osmotic agent peristaltic pump is arranged for replenishment of glucose solution to the fluid added to the peritoneal cavity for promoting ultrafiltration. The glucose is replenished intermittently for keeping a concentration of glucose substantially constant in the peritoneal cavity. The flow pump comprises a pressure chamber with rigid walls and a flexible pump bag arranged therein. An air pump pressurizes the chamber for outflow of fluid from the peritoneal cavity by a sub pressure and inflow of fluid to the peritoneal cavity by an overpressure, which pressures are maintained within safe limits.Type: ApplicationFiled: November 20, 2015Publication date: October 5, 2017Applicant: TRIOMED ABInventors: Mikael AXELSSON, Stefan LANDHOLM, Eva PERSSON, Hans BENGTSSON
-
Publication number: 20170072125Abstract: Method and apparatus for ultrafiltration of a patient being overhydrated due to congestive heart failure, comprising a cassette having four inlets/outlets. A patient tube is connected to a patient connector, intended to be connected to a patient line for access to a peritoneal cavity of the patient. The patient tube comprises a flow pump for addition and removal of a peritoneal fluid between the cassette and the peritoneal cavity. The fluid is introduced into an intermittent bag controlled by an intermittent valve and then returned the same way back to the peritoneal cavity. Glucose is metered into the fluid entering the peritoneal cavity by means of a glucose pump. Glucose is replenished continuously or intermittently for keeping a concentration of the osmotic agent substantially constant in the peritoneal cavity. After treatment, the peritoneal fluid is drained to a drain bag, wherein the drain tube comprises a drain valve and an albumin filter.Type: ApplicationFiled: February 27, 2015Publication date: March 16, 2017Applicant: TRIOMED ABInventors: Anders WALLENÅS, Lars WRAMNER, Stefan LANDHOLM
-
Publication number: 20150320922Abstract: A method of producing a copper-chitosan polymer material for adsorption of urea from a dialysis solution. A solid chitosan polymer material is immersed in a copper salt solution of a weak acid, such as copper acetate, for allowing the copper ions to complex with the chitosan polymer. The macroporous chitosan polymer membrane has a thickness of no more than about 200 ??? and has a pore size of between about 1 to 100 ???, for example 20 to 50 ???. Alternatively, solid chitosan fibers, solid chitosan particles or a chitosan gel bead can be complexed with copper acetate. The concentration of the copper acetate solution is above 50 mM whereby gel formation of the solid chitosan material is avoided during the complexation step.Type: ApplicationFiled: July 5, 2013Publication date: November 12, 2015Applicant: TRIOMED ABInventors: Carin MALMBORG, Nina MEINANDER
-
Publication number: 20150297815Abstract: A method of adsorption of potassium ions from a peritoneal dialysis fluid, which has been removed from the peritoneal cavity of a patient performing peritoneal dialysis for subsequent recirculation and introduction into the peritoneal cavity of the patient. The peritoneal dialysis fluid is passed through a potassium adsorbent, such as a zeolite, which has been pre-equilibrated with an equilibration fluid comprising Na+, Ca2+, Mg2+, Cl?, lactate, in substantially the same concentration as in the peritoneal dialysis fluid and which equilibration fluid lacks K+. The zeolite may be titrated with an acid. Alternatively, a zeolite having a Si:Al ratio which is larger than 5:1 is used. Alternatively, a cation exchange material, such as sodium polystyrene sulfonate, is used.Type: ApplicationFiled: November 22, 2013Publication date: October 22, 2015Applicant: TRIOMED ABInventor: Nina MEINANDER
-
Publication number: 20150290384Abstract: A regeneration circuit for regeneration of a dialysis fluid. An inlet and an outlet are arranged to pass a dialysis fluid to and from the regeneration circuit by means of a pump. An adsorbent cartridge is arranged downstream of the pump and comprises an adsorbent made of e.g. activated carbon and an adsorbent made of metal-complexed chitosan and possibly further adsorbents. Downstream of the last adsorbent is arranged a further general adsorbent arranged to adsorb metal ions, such as copper ions, possibly given off by previous adsorbents. Such a general adsorbent is an adsorbent made of uncomplexed chitosan, which adsorb metal ions and does not adsorb physiological electrolytes commonly included in a dialysis fluid, such as sodium, potassium, calcium and magnesium ions.Type: ApplicationFiled: November 22, 2013Publication date: October 15, 2015Applicant: TRIOMED ABInventor: Carin Malmborg
-
Publication number: 20150273131Abstract: Claims 1-5 relate to methods for treatment of the human or animal body by therapy, since the claims describe changing the compositions of the circulation dialysis fluid, which will affect the ion concentration in the patient's blood. See PCT rule 43bis.1 (b) and PCT rule 67.1.(iv). Nevertheless, an examination has been conducted for these claims. The examination has been made in respect of the technical content of the claims.Type: ApplicationFiled: November 22, 2013Publication date: October 1, 2015Applicant: TRIOMED ABInventors: Carin Malmborg, Nina Meinander
-
Patent number: 8282828Abstract: A method and a system for regenerating a body fluid, such as a peritoneal dialysis fluid. The body fluid is removed into an extracorporeal circuit comprising an electrofilter for removing charged ions from the body fluid, a nanofilter for removing large molecules, such as Dextran 40, and a reverse osmosis filter for concentrating the body fluid, for producing a synthetic urine to be discarded. The removed ions and large molecules are returned to the patient together with pure water from the reverse osmosis filter through an ultrafilter.Type: GrantFiled: August 16, 2007Date of Patent: October 9, 2012Assignee: Triomed ABInventor: Anders Wallenås
-
Patent number: 7976709Abstract: A system comprising a blood circuit including a membrane arranged in a blood filter (7) in which blood is in contact with a first side of said membrane; and a dialysis circuit in which a dialysis fluid is in contact with the other side of the membrane for exchange of substances and ions through the membrane as well as water. The dialysis fluid is circulated from a dialysis compartment and through a RO filter (9). The permeate fluid, i.e. water is returned to the dialysis compartment. The retentate fluid from the RO filter (9) passes through a separation filter (13). The retentate fluid is returned to the dialysis compartment and the permeate fluid is removed from the dialysis circuit as a waste fluid to a receptacle (19). The retentate fluid is concentrated in the RO filter in a ration of at least 3:1.Type: GrantFiled: February 16, 2006Date of Patent: July 12, 2011Assignee: Triomed ABInventors: Anders Wallenas, Lars Wramner